US HB4116 | 2017-2018 | 115th Congress
Status
Sponsorship: Partisan Bill (Democrat 34)
Status: Introduced on October 25 2017 - 25% progression, died in committee
Action: 2017-10-27 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on October 25 2017 - 25% progression, died in committee
Action: 2017-10-27 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Transparent Drug Pricing Act of 2017
Title
Transparent Drug Pricing Act of 2017
Sponsors
| Rep. Lloyd Doggett [D-TX] | Rep. Elijah Cummings [D-MD] | Rep. Rosa DeLauro [D-CT] | Rep. Keith Ellison [D-MN] |
| Rep. Mark Pocan [D-WI] | Rep. Raul Grijalva [D-AZ] | Rep. David Cicilline [D-RI] | Rep. Steve Cohen [D-TN] |
| Rep. John Conyers [D-MI] | Rep. Brian Higgins [D-NY] | Rep. Marcy Kaptur [D-OH] | Rep. Jerrold Nadler [D-NY] |
| Rep. Jamie Raskin [D-MD] | Rep. Pramila Jayapal [D-WA] | Sen. Peter Welch [D-VT] | Rep. Judy Chu [D-CA] |
| Rep. Henry Johnson [D-GA] | Rep. Earl Blumenauer [D-OR] | Rep. Chellie Pingree [D-ME] | Rep. Eleanor Norton [D-DC] |
| Rep. Ro Khanna [D-CA] | Rep. Al Green [D-TX] | Rep. Emanuel Cleaver [D-MO] | Rep. Carol Shea-Porter [D-NH] |
| Rep. Grace Napolitano [D-CA] | Rep. Vicente Gonzalez [D-TX] | Rep. Mark DeSaulnier [D-CA] | Rep. Gwen Moore [D-WI] |
| Rep. Luis Gutierrez [D-IL] | Rep. Bennie Thompson [D-MS] | Rep. Nydia Velazquez [D-NY] | Rep. Karen Bass [D-CA] |
| Rep. Mark Takano [D-CA] | Rep. Maxine Waters [D-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2017-10-27 | House | Referred to the Subcommittee on Health. |
| 2017-10-25 | House | Referred to the House Committee on Energy and Commerce. |
| 2017-10-25 | House | Introduced in House |
Subjects
Accounting and auditing
Business records
Congressional oversight
Corporate finance and management
Government studies and investigations
Health
Health care costs and insurance
Inflation and prices
Intellectual property
Marketing and advertising
Medical research
Prescription drugs
Product development and innovation
Research administration and funding
Research and development
Small business
Wages and earnings
Business records
Congressional oversight
Corporate finance and management
Government studies and investigations
Health
Health care costs and insurance
Inflation and prices
Intellectual property
Marketing and advertising
Medical research
Prescription drugs
Product development and innovation
Research administration and funding
Research and development
Small business
Wages and earnings
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/115th-congress/house-bill/4116/all-info |
| Text | https://www.congress.gov/115/bills/hr4116/BILLS-115hr4116ih.pdf |
